Home / Tag Archives: immuno-oncology

Tag Archives: immuno-oncology

Compugen Discloses Initial Experimental Results for Predicted Antibody Drug Conjugate Targets קומפיוג’ן: תוצאות ניסוייות חיוביות עבור 2 מ-5 חלבוני מטרה פוטנציאליים

Compugen, a drug discovery company that uses computational biology to predict and select product candidates, announced positive initial experimental results for the first two of five in silico-predicted targets for antibody drug conjugate (ADC) cancer therapy disclosed in late 2013. ...

Read More »

Compugen Announces Cancer Research Collaboration with Johns Hopkins University קומפיוג'ן הודיעה על שיתוף פעולה עם אוניברסיטת ג'ונס הופקינס במחקר על סרטן

Compugen (NASDAQ:CGEN; TASE:CGEN) has entered into a multi-year research collaboration with Johns Hopkins University School of Medicine to evaluate novel “immune checkpoint” candidates discovered by Compugen for potential treatment of cancer. The research will be directed by Johns Hopkins University’s Prof. Drew Pardoll ...

Read More »